[123I] AV39
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [123I] AV39, covering 2008-04-24 to 2008-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects [Phase 1]